Latest News about FDA
Recent news which mentions FDA
From Benzinga
FDA Strikes Out Intercept Pharma's Obeticholic Acid Application For NASH Patients, Focus Shifts To Rare Liver Diseases
June 23, 2023
Tickers
ICPT
From Benzinga
Sarepta Therapeutics' Therapy Becomes First To Score FDA Nod For Duchenne Muscular Dystrophy Gene Therapy
June 22, 2023
Tickers
SRPT
From Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
From Benzinga
From Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
June 20, 2023
From Benzinga
Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
June 16, 2023
From Benzinga
FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition
June 16, 2023
Tickers
GSK
From Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
June 15, 2023
From Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.